Business
Press Release May 08 2025
Lupin Limited has informed the Exchange regarding a press release dated May 08, 2025, titled "Lupin Receives Approval from U.S. FDA for Raltegravir Tablets USP, 600 mg".
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange regarding a press release dated May 08, 2025, titled \"Lupin Receives Approval from U.S. FDA for Raltegravir Tablets USP, 600 mg\". View Attachment","length":333,"tagName":"div"}]